Bridgeway Capital Management »

Cartesian Therapeutics shares owned by Bridgeway Capital Management

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by Bridgeway Capital Management from 13F filings

Historical chart of Bridgeway Capital Management investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by Bridgeway Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by Bridgeway Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $256k 25k 10.22
2024-09-30 $164k 10k 16.12
2024-06-30 $275k 10k 27.01